Drug Patents owned by Jazz Pharms

1. List of Xyrem drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8731963 JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2022

(a month ago)

US8731963

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2023

(4 months from now)

US7668730 JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2024

(1 year, 4 months from now)

US7668730

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2024

(1 year, 10 months from now)

US10864181 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US11253494 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US10213400 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US9486426 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US9050302 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US8772306 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(10 years from now)

US8772306

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

US9486426

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

US9050302

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

US10864181

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

US11253494

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

US10213400

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(10 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Oct 26, 2025
Pediatric Exclusivity (PED) Apr 26, 2022

Drugs and Companies using SODIUM OXYBATE ingredient

Market Authorisation Date: 17 July, 2002

Treatment: Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with sodium oxybate when divalproex sodium is concomitantly administered.; Method of reducing adverse effects in patients who are concomitantly administered a salt of gamma-hydroxybutyrate and divalproex sodium; Method of treating patients with a salt of gamma-hydroxybutyrate when divalproex sodium is concomitantly administered; Method of reducing adverse effects in patients suffering from excessive daytime sleepiness and/or cataplexy in narcolepsy who are concomitantly administered sodium oxybate and divalproex sodium

Dosage: SOLUTION;ORAL

How can I launch a generic of XYREM before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in